hs-CRP versus fasting insulin | |||||
<5 | 5–10 | 10–15 | >15 | p Value | |
Mean hs-CRP (mg/L) | |||||
Unadjusted | 0.88±0.06 | 1.07±0.07 | 1.63±0.20 | 1.92±0.20 | <0.001 |
Model I | 0.86±0.06 | 1.08±0.07 | 1.65±0.20 | 1.94±0.20 | <0.001 |
Model II | 0.86±0.06 | 1.07±0.07 | 1.66±0.20 | 1.95±0.20 | <0.001 |
High-risk hs-CRP (hs-CRP>2 mg/L) (%) | |||||
Unadjusted | 7.92±0.97 | 9.80±1.08 | 19.30±2.74 | 28.29±4.04 | <0.001 |
Model I | 7.70±0.98 | 9.88±1.08 | 19.52±2.74 | 28.44±4.06 | <0.001 |
Model II | 7.75±0.99 | 9.78±1.07 | 19.68±2.73 | 28.54±4.04 | <0.001 |
Data are presented with survey means ± SE.
Model I: adjusted for sex, age.
Model II: adjusted for model I + alcohol, smoking, exercise, total energy intake.
hs-CRP, high-sensitivity C reactive protein.